Monotherapy Administration of Sorafenib in Patients with Non-Small Cell Lung Cancer

1 Views
administrator
administrator
07/07/23

Vienna, ESMO 2012, Pressconference September 29: Dr Luis Paz-Ares, Oncology Service, Hospital Virgen del Roc, Seville/SPAIN
Monotherapy Administration of Sorafenib in Patients with Non-Small Cell Lung Cancer: Phase III, Randomized, Double-Blind, Placebo-Controlled MISSION Trial.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next